Delivery Order SPE2DB20D7059-SPE2DB25FQGM7

Award Date 5/15/25
Potential Completion Date 5/16/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,113.36 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of a specific medical inhaler product, BREYNA 160-4.5 MCG INHALER 10.3GM, with a period of performance running through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a specific medical inhaler product, "BREYNA 160-4.5 MCG INHALER 10.3GM", with a firm fixed price of $6,709.07 and a performance period through April 15, 2025. The contract is not set-aside and is considered an open competition award. Amerisourcebergen Drug Corp holds a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a medical inhaler product, BREYNA 160-4.5 MCG INHALER 10.3GM, with a ceiling value of $5,740.40 and a period of performance through April 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,759.66, is for the provision of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the BREYNA 160-4.5 MCG INHALER 10.3GM medication. The contract has a firm fixed price of $2,428.87 and an ultimate completion date of September 20, 2024. Amerisourcebergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,694.03, is for the procurement of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,270.34, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. The contract is a firm fixed-price delivery order with a completion date of March 19, 2025. The award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a medical inhaler product, specifically the BREYNA 160-4.5 MCG INHALER 10.3GM, with a ceiling value of $9,428.03 and a period of performance through February 6, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,980.39 firm fixed-price contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical supply product. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 80-4.5 MCG INHALER 10.3GM, a medical product, with a ceiling value of $1,151.55 and a period of performance through April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. The award is part of Amerisourcebergen's larger...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQGM7
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a medical inhaler product called BREYNA 160-4.5 MCG INHALER 10.3GM. The $1,000.20 firm fixed-price contract has a completion date of May 16, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 8/14/25, 9:58 AM